research

Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Pelthos Therapeutics reported Q4 2025 financial results on March 19, 2026, detailing fiscal year performance through December 31, 2025. CEO Scott Plesha led the earnings call, highlighting key operational and financial milestones. The company emphasized forward-looking statements, cautioning investors about risks tied to projections. Management clarified these statements reflect current expectations but carry uncertainties that could impact future performance. CFO Francis Knuettel and Chief Commercial Officer Sai Rangarao joined the call, addressing analyst questions from firms like Lake Street Capital and Piper Sandler. Topics included financial health and strategic growth plans. Analysts from Oppenheimer, H.C. Wainwright, and Alliance Global Partners participated, probing revenue drivers and R&D progress. The call underscored Pelthos’ focus on transparency amid market volatility. A recording of the call will remain accessible for 90 days, per company policy. No updates to forward-looking statements are guaranteed, even if conditions change.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts159.05K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call March 19, 2026 8:00 AM EDT Company Participants Scott Plesha - CEO, President & DirectorSai Rangarao - Chief Commercial OfficerFrancis Knuettel - CFO, Secretary & Treasurer Conference Call Participants Mike MoyerThomas Flaten - Lake Street Capital Markets, LLC, Research DivisionBrandon Folkes - H.C. Wainwright & Co, LLC, Research DivisionDavid Amsellem - Piper Sandler & Co., Research DivisionJeffrey Jones - Oppenheimer & Co. Inc., Research DivisionJames Molloy - Alliance Global Partners, Research Division Presentation Mike Moyer Good morning, everyone, and welcome to Pelthos Therapeutics 2025 Fourth Quarter and Fiscal Year Financial Results Conference Call. Pelthos issued a press release today announcing its financial results for the year ended December 31, 2025. A copy can be found in the Investor Relations tab on the corporate website at www.pelthos.com. Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our current expectations expressed or implied by the forward-looking statements. Any such forward-looking statements represent management's estimates as of the date of this conference call. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent events cause its views to change. As a reminder, this conference call is being recorded and will remain available for 90 days. I'd now like to turn the floor over to Scott Plesha, Chief Executive Officer. Sir, you may begin. Scott PleshaCEO, President & Director Thank you, Mike. Good

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.